Search company, investor...


Founded Year



Acquired | Acquired

Total Raised




About Arryx

Arryx, Inc is now a wholly-owned subsidiary of Haemonetics. Arryx Research facilities, personnel, and operations will remain in Chicago.nHaemonetics (NYSE: HAE) is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collection, plasma collection, and blood component safety.

Headquarters Location

316 North Michigan Avenue Suite 400

Chicago, Illinois, 60601,

United States


Missing: Arryx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Arryx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Arryx Patents

Arryx has filed 16 patents.

patents chart

Application Date

Grant Date


Related Topics




Analytical chemistry, Chromatography, Violence against women, Spectroscopy, Mass spectrometry


Application Date


Grant Date



Related Topics

Analytical chemistry, Chromatography, Violence against women, Spectroscopy, Mass spectrometry



Arryx Frequently Asked Questions (FAQ)

  • When was Arryx founded?

    Arryx was founded in 2000.

  • Where is Arryx's headquarters?

    Arryx's headquarters is located at 316 North Michigan Avenue, Chicago.

  • What is Arryx's latest funding round?

    Arryx's latest funding round is Acquired.

  • How much did Arryx raise?

    Arryx raised a total of $10.75M.

  • Who are the investors of Arryx?

    Investors of Arryx include Haemonetics, Threshold Ventures, Nanostart, ARCH Development Partners, Fahnestock Venture Capital Fund and 3 more.

  • Who are Arryx's competitors?

    Competitors of Arryx include Velico Medical, Mercator MedSystems, Verax Biomedical, Amsino International, Abaxis and 10 more.

Compare Arryx to Competitors

Verax Biomedical

Verax Biomedical is the producer of the Platelet PGD Test, a test for bacterial contamination in platelets granted a Safety Measure claim by the FDA. The test can be used to extend the dating of apheresis platelets in plasma, the most common platelet type transfused in the U.S., from 5 to 7 days. This dating extension offers the opportunity for significant cost savings to the blood banking community while preserving a critical life giving resource.

Velico Medical

Velico Medical, fka ZymeQuest, is engaged in the discovery, development and commercialization of enzymatic blood conversion processing systems for use in blood transfusion medicine. Enzymatic blood conversion aims to enable the precise and permanent conversion of groups A, B and AB red blood cells to ECO (Enzyme Converted O) red blood cells.

Pulse Metric

Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.


Cardiophotonics develops non invasive blood monitors used to detect cardiac arrhythmia and dehydration


Founded in 1998, Investigen, Inc., is an innovator in DNA testing, developing new processes to shorten testing time and reduce the cost of DNA diagnostic testing and detection of microorganisms and genetically modified organisms (GMOs). Investigen's tests have already demonstrated significant value for food quality assurance, health care, environmental safety, and industry.http://www.investigen.comDidier Perez, Phone: 510-964-9700, Email:


Lifepoint is a medical technology company developing rapid and cost effective, non-invasive, on-site diagnostic products. The Company has developed and will continue to develop patented, proprietary technologies utilizing saliva as a test specimen to provide blood equivalent diagnostic results without the need for blood or urine.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.